Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > PEA assumptions

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon May 04, 2024 1:38pm

103 Views

Post# 36023354

RE:RE:PEA assumptions

Assume the cost for VM to buy feedstock is the same as what was assumed from mining.

	Year 1 PEA		Year 1 PEA
Revenue	55,000,000	Revenue	29,268,000
FC mining	(3,000,000)	FC mining	(3,000,000)
Upgrade processing	(2,000,000)	Upgrade processing	(2,000,000)
Pharma COGS	(8,000,000)	Pharma COGS	(8,000,000)
Royalty	(1,000,000)	Royalty	0
Quarry G&A	(2,000,000)	Quarry G&A	0
Before tax	39,000,000	Before tax	16,268,000
Tax	(9,000,000)	Tax	(4,067,000)
After tax	30,000,000	After tax	12,201,000